ArticleACS medicinal chemistry letters2011

Development of Polar Adenosine A2A Receptor Agonists for Inflammatory Bowel Disease: Synergism with A2B Antagonists.

Ali El-Tayeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.